Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic

Tropical Medicine and International Health

Volumn 9, Issue 11, 2004, Pages 1175-1183

  Stohrer, Jörg M ^a,g   Dittrich, Sabine ^a,g   Thongpaseuth, Vonthalom ^b   Vanisaveth, Viengxay ^b   Phetsouvanh, Rattanaxay ^b   Phompida, Samlane ^b   Monti, Feliciano ^c   Christophel, Eva Haria ^d   Lindegardh, Niklas ^e,f   Annerberg, Anna ^e,f   Jelinek, Tomas ^a,g  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Ctr Malariology   (Laos)

^c WHO Office Lao PDR   (Laos)

^d The World Health Organization Regional Office for the Western Pacific philippines   (Philippines)

^e CHURCHILL HOSPITAL   (United Kingdom)

^f MAHIDOL UNIVERSITY   (Thailand)

^g Institute of Tropical Medicine   (Germany)

Author keywords

Artemether lumefantrine; Artesunate mefloquine; Efficacy; Lao PDR; Malaria; Plasmodium falciparum

Indexed keywords

ANTIBIOTIC AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; CHLOROQUINE; FANSIDAR; MEFLOQUINE; PARACETAMOL; QUININE;

DISEASE CONTROL; HEALTH MONITORING; MALARIA; PERFORMANCE ASSESSMENT;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ANOREXIA; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG BIOAVAILABILITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; ENDEMIC DISEASE; FEMALE; FOLLOW UP; HEADACHE; HUMAN; LAOS; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MUSCLE WEAKNESS; NAUSEA; OPEN STUDY; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; STATISTICAL ANALYSIS; VOMITING;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIMALARIALS; ARTEMISININS; BIOLOGICAL AVAILABILITY; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; KOREA; MALARIA, FALCIPARUM; MALE; MEFLOQUINE; MIDDLE AGED; PARASITEMIA; SESQUITERPENES; TREATMENT OUTCOME;

ASIA; EASTERN HEMISPHERE; EURASIA; LAOS; LUANG NAMTHA; SOUTHEAST ASIA; WORLD;

ARTESUNATE; CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PROTOZOA;

EID: 9644287921     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2004.01320.x     Document Type: Article

References (24)

1. Adjuik M, Babiker A, Garner P et al. (2004) Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363, 9-17.
2. Cattamanchi A, Kyabayinze D, Hubbard A et al. (2003) Distinguishing recrudescence from reinfection in a longitudinal anti-malarial drug efficacy study: comparison of results based on genotyping of msp-1, msp-2, and glurp. American Journal of Tropical Medicine and Hygiene 68, 133-139.
3. Ezzet F, Mull R & Karbwang J (1998) The population pharmacokinetics of CGP 56697 (artemether + benflumetol) and its effects on the therapeutic response in malaria patients. British Journal of Clinical Pharmacology 46, 553-561.
4. Ezzet F, van Vugt M, Nosten F et al. (2000) Pharmacokinetics and pharmacodynamics of lumefantrine in acute falciparum malaria. Antimicrobial Agents and Chemotherapy 44, 697-704.
5. Guthmann JP, Kasparian S, Nathan N et al. (2002) The efficacy of chloroquine for the treatment of acute uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic. Annals of Tropical Medicine and Parasitology 96, 553-557.
6. Schliesinger J (2003) Ethnic Groups of Laos. Volume 1. Introduction and Overview. White Lotus Press, Bangkok.
7. Levfèvre G, Looaresuwan S, Treeprasertsuk S et al. (2001) A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. American Journal of Tropical Medicine and Hygiene 64, 247-256.
8. Mayxay M, Newton NP, Khanthavong M et al. (2003) Chloroquine versus sulfadoxine-pyrimethamine for treatment of Plasmodium falciparum malaria in Savannakhet Province, Lao People's Democratic Republic: an assessment of national anti-malarial drug recommendations. Clinical Infectious Diseases 37, 1021-1028.
9. Mayxay M, Newton PN, Khantavong M et al. (2004) Randomized comparison of plus sulphadoxine-pyrimethanmine versus artesunate plus mefloquine versus Artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in Lao PDR (Laos). (in press): Clinical Infectious Diseases.
10. Ministry of Health Lao PDR (2002) Annual Malaria Reports to the WHO. WHO, Geneva. Available at: http://www.wpro.who.int/.
11. Price RN, Nosten F, Luxemburger C et al. (1997) Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 91, 574-577.
12. Price R, Nosten F, Simpson JA et al. (1999) Risk Factors for Gametocyte Carriage in Uncomplicated Falciparum Malaria. American Journal of Tropical Medicine and Hygiene 60, 1019-1023.
13. Schwoebel B, Jordan S, Vanisaveth V et al. (2003) Therapeutic efficacy of chloroquine plus sulfadoxine/pyrimethamine compared with monotherapy with either chloroquine or sulfadoxine/pyrimethamine in uncomplicated Plasmodium falciparum malaria in Laos. Tropical Medicine and International Health 8, 19-24.
14. Simpson JA, Watkins ER, Price R et al. (2000) Mefloquine Pharmacokinetic-Pharmacodynamic Models: Implications for Dosing and Resistance. Antimicrobial Agents and Chemotherapy 44, 3414-3424.
15. Sintasath DM (2000) The distribution and quality of anti-malarial drugs in the Lao People's Democratic Republic. Master's Thesis, London School of Hygiene and Tropical Medicine, London.
16. Suputtamongkol Y, Chindarat S, Silpasakorn S et al. (2003) The efficacy of combined mefloquine-artesunate versus mefloquine-primaquine on subsequent development of plasmodium falciparum gametocytemia. American Journal of Tropical Medicine and Hygiene 68, 620-623.
17. van Vugt M, Brockman A, Gemperli B et al. (1998) Randomised comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria. Antimicrobial Agents and Chemotherapy 42, 135-139.
18. van Vugt M, Wilairatana P, Gemperli I et al. (1999) Efficacy of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. American Journal of Tropical Medicine and Hygiene 60, 936-942.
19. van Vugt M, Looareesuwan S, Wilairatana P et al. (2000) Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 94, 545-548.
20. White NJ, van Vugt M & Ezzet F (1999) Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine. Clinical Pharmacokinetics 37, 105-125.
21. World Health Organization (2000) Severe falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 94 (Suppl. 1), 1-90.
22. World Health Organization (2000) Challenges of Antimalarial Drug Policy and Drug Resistance in the WHO Western Pacific Region. Report of an Informal Consultation. WHO, Geneva.
23. World Health Organization (2001) Antimalarial Drug Combination Therapy. Unpublished Report of a WHO Technical Consultation. (WHO/CDS/RBM/2001.35). WHO, Geneva.
24. World Health Organization (2003) Assessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria, (WHO/HTM/RBM/2003.50). WHO, Geneva.